Termination Not Sole Remedy. Termination is not the sole remedy under this Agreement and, whether or not termination is effected and notwithstanding anything contained [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. in this Agreement to the contrary, all other remedies will remain available except as agreed to otherwise herein.
Appears in 3 contracts
Sources: License and Collaboration Agreement (Portola Pharmaceuticals Inc), License and Collaboration Agreement (Portola Pharmaceuticals Inc), License and Collaboration Agreement (Portola Pharmaceuticals Inc)
Termination Not Sole Remedy. Termination is not the sole remedy under this Agreement and, whether or not termination is effected and notwithstanding anything contained effected, all other remedies will remain available except as agreed to otherwise herein. [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. in Confidential treatment has been requested with respect to this Agreement to the contrary, all other remedies will remain available except as agreed to otherwise hereininformation.
Appears in 2 contracts
Sources: Drug Discovery Collaboration Agreement (Loxo Oncology, Inc.), Drug Discovery Collaboration Agreement (Loxo Oncology, Inc.)
Termination Not Sole Remedy. Termination is not the sole remedy under this Agreement and, whether or not termination is effected and notwithstanding anything contained [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. in this Agreement to the contrary, all other remedies will remain available except as agreed to otherwise herein. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
Appears in 1 contract
Termination Not Sole Remedy. Termination is not the sole remedy under this Agreement and, whether or not termination is effected and notwithstanding anything contained [*in this Agreement to the contrary, all other remedies shall remain available except as agreed to otherwise herein. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 rule 24b-2 of the Securities Exchange Act of 19331934, as amended. in this Agreement to the contrary, all other remedies will remain available except as agreed to otherwise herein.
Appears in 1 contract
Sources: License and Collaboration Agreement (Cytokinetics Inc)
Termination Not Sole Remedy. Termination is not the sole remedy under this Agreement and, whether or not termination is effected and notwithstanding anything contained in this Agreement to the contrary, all other remedies shall remain available except as agreed to otherwise herein. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934, as amended. in this Agreement to the contrary, all other remedies will remain available except as agreed to otherwise herein.
Appears in 1 contract
Sources: Collaboration and License Agreement (Sangamo Therapeutics, Inc)